We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test for Predicting Childhood Diabetes Reconsidered

By LabMedica International staff writers
Posted on 18 Mar 2011
Print article
The glycosalated hemoglobin (HbA1c) blood test is a rapid and convenient way of diagnosing diabetes.

The HbA1c test has become the preferred way to diagnose diabetes among the millions of patients who have the disease, but are asymptomatic. The simple test measures longer-term blood sugar levels without requiring patients to fast overnight.

Scientists at the University of Michigan, (Ann Arbor, MI, USA), studied whether the assay could be used to make a diagnosis of diabetes mellitus in adolescents, using the standardized values for adults. For the study, they evaluated the testing results of 1,156 obese and overweight adolescents, aged 12-18 years. The American Diabetes Association, (Alexandria, VA, USA), recommends screening only obese and overweight children because their weight puts them at higher risk for developing diabetes.

Individuals were defined as having diabetes mellitus if their fasting plasma glucose (FPG) was equal to or greater than 126 mg/dL; a 2-hour plasma glucose (2-hr PG) equal to or greater than 200 mg/dL or were prediabetic where the FPG is between 100 and 126 mg/dL; and the 2-hr PG is between 140 and 200 mg/dL. According to the guidelines, individuals without symptoms would be classified as having diabetes if HbA1c values reach 6.5% and as having prediabetes if HbA1c values were between 6.0% and 6.4% on two separate tests.

Only four of the adolescents studied had undiagnosed diabetes mellitus. When assessing FPG to detect diabetes, an HbA1c of 6.5% had sensitivity rates of 75.0% for adolescents and 53.8% adults, although the specificity was higher. Additionally, when assessing FPG to detect diabetes mellitus, an HbA1c of 5.7% had sensitivity rates of 5.0% and 23.1%, and specificity rates of 98.3% and 91.1% for adolescents and adults, respectively. These analyses suggest that HbA1c is a poorer predictor of diabetes mellitus and prediabetes for adolescents compared with adults and performance was poor regardless of whether FPG or 2-hr PG measurements were used.

Joyce M. Lee, MD, MPH, a pediatric endocrinologist, and lead author of the study, said, "We found that hemoglobin A1c is not as reliable a test for identifying children with diabetes and prediabetes compared with adults and using this test in children may lead to missed cases." The study was published online ahead of print on December 30, 2010, in the Journal of Pediatrics.

Related Links:

University of Michigan

American Diabetes Association
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Gold Member
Troponin T QC
Troponin T Quality Control
New
DNA Extraction Kit
Ron’s Gel Extraction Mini Kit
New
Urine Control
MassCheck Amino Acid Analysis Urine Controls

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.